Intra-Abdominal Infection clinical trials at University of California Health

1 research study open to eligible people

Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI)
open to eligible people ages 8-17
A Phase 2 trial to assess safety, tolerability, and pharmacokinetics of eravacycline in pediatric patients aged 8 to <18 years with cIAI.
at UCLA

Last updated: October 27, 2025